Givaudan | GIVN - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Air Liquide EUR 3.96B 2.05B 2025-12
Akzo Nobel EUR 1.62B 66M 2025-12
Anheuser-Busch USD 11.53B 4.47B 2025-12
Arkema EUR 2.19B 235M 2025-12
Associated British Foods GBP 1.06B 299M 2025-06
BASF EUR 2.67B 811M 2025-12
Bayer EUR 6.67B 774M 2025-12
Beiersdorf EUR 1.2B 33M 2025-12
British American Tobacco GBP 4.4B 1.53B 2025-06
Covestro EUR 648M 44M 2025-12
Croda International GBP 157.8M 9M 2025-06
Danone EUR 1.98B 364M 2025-12
Diageo GBP 2.2B 544M 2025-06
Fresenius EUR 1.31B 81M 2025-12
Fresenius Medical Care EUR 1.24B 343.37M 2026-03
Givaudan CHF 603M 3M 2024-06
Glanbia EUR 417M 116.1M 2025-01
Heineken EUR 2.07B 284M 2025-06
Henkel EUR 2.71B 163M 2025-12
International Flavors Fragrances USD 562M 28M 2026-03
Johnson Matthey GBP 542M 49M 2024-06
Lonza CHF 719M 188M 2025-12
L'Oréal EUR 9.86B 5.04B 2025-12
Merck EUR 2.33B 77M 2025-12
Nestle CHF 4.58B 73M 2025-12
Pernod Ricard EUR 2.4B 569M 2025-12
Reckitt Benckiser GBP 880M 106M 2024-12
SGS CHF 1.21B 78M 2024-12
Sika AG CHF 1.87B 1.18B 2022-12
Solvay EUR 486M 50M 2026-03
Tate & Lyle GBP 475M 41M 2023-06
Umicore EUR 1.56B 450.17M 2025-12
Victrex GBP 58.7M 13M 2022-12